Redhill Biopharma

Redhill Biopharma

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$0.49
Previous Close
$0.50
Day Range
$0.49-$0.49
52W Range
$0.50-$2.61
Market Cap
$3M
Shares Short
235,258

Financials

See more
Revenue (12 Mos)
$286,000
Revenue Growth (YoY)
58.6%
Gross Profit (12 Mos)
$286,000
Diluted EPS
$0

News

See more

Yahoo Finance • 18 days ago

RedHill (RDHL) Acquires Rebyota and Clenpiq Commercialization Rights for $12M Upfront. Can Sales Outpace Royalties?

Yahoo Finance • 28 days ago

RedHill Biopharma divests Talicia to Apotex for $18M upfront

Yahoo Finance • 2 months ago

Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight

Yahoo Finance • 7 months ago

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight

About

CEO
Mr. Dror Ben-Asher
Address
21 Ha?arba?a Street, Tel Aviv-Yafo, Israel, 6473921
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-Time Employees
13